Cargando…
The Effect of Curcumin on some of Traditional and Non-traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-blind, Placebo-controlled Trial
Numerous interventional studies in clinical and preclinical setting stated that intake of curcumin may provide protection against cardiovascular disease. The aim of this trial was investigation of curcumin efficiency on some cardiovascular risk factors in patients with coronary artery disease (CAD)....
Autores principales: | Mirzabeigi, Parastoo, Mohammadpour, Amir Hooshang, Salarifar, Mojtaba, Gholami, Kheirollah, Mojtahedzadeh, Mojtaba, Javadi, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403064/ https://www.ncbi.nlm.nih.gov/pubmed/25901155 |
Ejemplares similares
-
Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial
por: Mohebbi, Niayesh, et al.
Publicado: (2014) -
Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-selectin and hs-CRP Level in Patients with Venous Thromboembolism; the First Study of Iranian Population
por: Entezari-Maleki, Taher, et al.
Publicado: (2014) -
Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial
por: Sanaie, Sarvin, et al.
Publicado: (2014) -
Hypericum perforatum: Traditional uses, clinical trials, and drug interactions
por: Nobakht, Seyedeh Zahra, et al.
Publicado: (2022) -
Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial
por: Nasiripour, Somayyeh, et al.
Publicado: (2014)